Tag: peptide therapeutics industry research

  • Comprehensive Peptide Therapeutics Market Analysis 2024: Size, Share, And Key Trends

    Comprehensive Peptide Therapeutics Market Analysis 2024: Size, Share, And Key Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Peptide Therapeutics Market from 2024 to 2033?

    The size of the peptide therapeutics market has increased significantly in the last few years. Its growth is projected to rise from $41.44 billion in 2023 to $45.66 billion in 2024, registering a Compound Annual Growth Rate (CAGR) of 10.2%. The historical growth of the market is due to factors such as escalating cases of chronic illnesses, a better comprehension of molecular biology, and burgeoning applications in the field of oncology.

    The market size for peptide therapeutics is predicted to surge in the upcoming years, reaching a valuation of $68.83 billion in 2028 with a compound annual growth rate (CAGR) of 10.8%. The projected rise during this period could be due to the escalating need for personalized medicine, widening applications in immunotherapy, breakthroughs in peptide delivery systems, and novel peptide targets for infectious diseases, as well as an amplified focus on rare diseases. Key trends for the future entail technological progress in peptide synthesis, an increase in investments and funding, a concentration on the safety of peptide drugs, expanding markets in developing economies, and the incorporation of artificial intelligence (AI).

    Claim Your Free Sample of the Global Peptide Therapeutics Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

    What Key Factors Are Fueling the Growth of the peptide therapeutics Market?

    The rise in long-lasting disease prevalence is likely to spur the peptide therapeutics market growth. These are ailments that usually last a long time and can seldom be entirely cured, but can sometimes be cured and managed. Increased tobacco consumption, poor diet, lack of physical activity, excess alcohol intake, and other factors contribute to the rise of these diseases. Peptide therapeutics proves to be beneficial in the prevention and treatment of certain long-lasting diseases. For instance, according to a future prediction made by the US-based National Library of Medicine in January 2023, the number of Americans 50 years and older with at least one long-lasting ailment is expected to jump by 99.5%, reaching 142.66 million by 2050. Thus, the increasing prevalence of long-lasting diseases is anticipated to motivate the peptide therapeutics market expansion during the projected period.

    What Are the Major Segments of the Peptide Therapeutics Market?

    1) By Type: Generic, Branded

    2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal

    3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications

    Order Now for Fast Delivery of Your Peptide Therapeutics Market Report!

    https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

    Which Regions Are Driving Growth in the Peptide Therapeutics Market?

    North America was the largest region in the peptide therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Peptide Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the peptide therapeutics market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Peptide Therapeutics Market Include

    1. Peptide Therapeutics Market Executive Summary

    2. Peptide Therapeutics Market Segments

    3. Peptide Therapeutics Market Size And Template Market Growth Rate

    4. Key Peptide Therapeutics Market Trends

    5. Major Peptide Therapeutics Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Peptide Therapeutics Market

    26. Top Peptide Therapeutics Companies

    27. Peptide Therapeutics Market Opportunities And Strategies

    28. Peptide Therapeutics Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Peptide Antibiotics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

    Blood Culture Tests Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report

    Nutraceuticals Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/nutraceuticals-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Peptide Therapeutics Market 2024

    5 Key Insights On The Peptide Therapeutics Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Peptide Therapeutics Global Market Report 2024, the peptide therapeutics market is expected to show significant growth in the forecast period.

    The peptide therapeutics market has experienced substantial growth in recent years and is poised for continued expansion. This blog explores the factors driving this growth, key trends, and future projections for the market.

    Current Market Size and Growth Rate

    • Market Size and Growth:
      • The peptide therapeutics market grew from $41.44 billion in 2023 to $45.66 billion in 2024, with a CAGR of 10.2%.
      • By 2028, the market is expected to reach $68.83 billion, growing at a CAGR of 10.8%.
    • Historical Growth Drivers:
      • Increasing incidence of chronic diseases.
      • Growing understanding of molecular biology.
      • Expanding applications in oncology.

    View More On The Peptide Therapeutics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

    Future Market Growth Drivers

    • Rising Demand for Personalized Medicine:
      • Personalized medicine tailors treatments to individual patients, increasing the effectiveness of peptide therapeutics.
    • Expanding Use in Immunotherapy:
      • Immunotherapy uses the body’s immune system to fight diseases, and peptides play a crucial role in these treatments.
    • Advancements in Peptide Delivery Systems:
      • New delivery systems improve the efficacy and safety of peptide therapeutics.
    • Emerging Peptide Targets in Infectious Diseases:
      • Peptides are being explored as treatments for various infectious diseases.
    • Increasing Focus on Rare Diseases:
      • Peptide therapeutics offer potential treatments for rare and orphan diseases.

    Trends Shaping the Future of Peptide Therapeutics

    • Technological Advancements in Peptide Synthesis:
      • Innovations in synthesis techniques enhance the development of new peptide drugs.
    • Growing Investment and Funding:
      • Increased funding supports research and development in peptide therapeutics.
    • Emphasis on Peptide Drug Safety:
      • Ensuring the safety of peptide drugs is paramount to their success and adoption.
    • Market Expansion in Emerging Economies:
      • Expanding into emerging markets offers significant growth opportunities.
    • Integration of Artificial Intelligence (AI):
      • AI aids in the discovery and development of new peptide drugs.

    Rising Prevalence of Chronic Diseases Propels Market Growth

    • Chronic Diseases Driving Market Growth:
      • Chronic diseases are long-lasting conditions that are often controllable but not curable.
      • Increased use of tobacco, poor nutrition, physical inactivity, and excessive alcohol use contribute to chronic diseases.
    • Peptide Therapeutics for Chronic Diseases:
      • Peptide therapeutics help prevent and treat various chronic diseases.
      • For example, the number of people aged 50 and older with at least one chronic condition in the US is projected to increase by 99.5% by 2050.

    Key Players in the Peptide Therapeutics Market

    • Major Companies:
      • Pfizer Inc.
      • Johnson & Johnson
      • AbbVie Inc.
      • Novartis AG
      • Bristol-Myers Squibb Company
      • AstraZeneca PLC
      • Amgen Inc.
      • Novo Nordisk AS
      • Teva Pharmaceuticals Industries Ltd.
      • Bachem Holding AG
      • PolyPeptide Laboratories BV
      • Arcus Biosciences Inc.
      • Anaptys Bio Inc.
      • Endoceutics Inc.
      • Pepscan Therapeutics
      • Peptech Inc.
      • Merck & Co Inc.

    Innovative Advancements in Peptide Therapeutics

    • Evonik’s Breakthrough in Cell Culture Processes:
      • In June 2023, Evonik Industries AG launched cQrex KC, a next-generation peptide for biopharma applications.
      • cQrex KC optimizes cystine supply and increases cell culture productivity, supporting the development of vaccines, viral vectors, and cell therapies.

    Strategic Acquisitions and Market Expansion

    • Bayer’s Acquisition of Vividion Therapeutics:
      • In August 2021, Bayer acquired Vividion Therapeutics to enhance its small molecule expertise and drug discovery capabilities.

    Market Segmentation

    • By Type:
      • Generic
      • Branded
    • By Route of Administration:
      • Parenteral
      • Mucosal
      • Oral
      • Transdermal
    • By Application:
      • Cancer
      • Cardiovascular Diseases
      • Central Nervous Systems
      • Metabolic Disorders
      • Infections
      • Hematological Disorders
      • Gastrointestinal Disorders
      • Dermatology
      • Respiratory Disorders
      • Acromegaly
      • Other Applications

    Regional Insights

    • North America:
      • North America was the largest region in the peptide therapeutics market in 2023.
    • Asia-Pacific:
      • Asia-Pacific is expected to be the fastest-growing region during the forecast period.

    Conclusion

    The peptide therapeutics market is set for continued rapid growth, driven by rising prevalence of chronic diseases, advancements in technology, and expanding applications. With ongoing innovations and strategic expansions, the market is well-positioned to meet the growing demand for effective and personalized treatments.

    Request A Sample Of The Global Peptide Therapeutics Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=7216&type=smp